6 news items
Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday
ADTN
AMBC
AORT
7 May 24
Yigal Nochomovitz initiated coverage on Summit Therapeutics with a Buy rating and announced a price target of $7.
Hims & Hers
Stifel Maintains Buy on Artivion, Raises Price Target to $25
AORT
7 May 24
Stifel analyst Rick Wise maintains Artivion (NYSE:AORT) with a Buy and raises the price target from $22 to $25.
Breaking Down Artivion: 4 Analysts Share Their Views
AORT
7 May 24
0
The 12-month price targets, analyzed by analysts, offer insights with an average target of $25.5, a high
Needham Maintains Buy on Artivion, Raises Price Target to $30
AORT
7 May 24
Needham analyst Mike Matson maintains Artivion (NYSE:AORT) with a Buy and raises the price target from $25 to $30.
Artivion Reports First Quarter 2024 Financial Results
AORT
6 May 24
full year revenue expectations and remain confident in our ability to meet or exceed our adjusted EBITDA target for 2024
x07gfakup
AORT
8 Apr 24
Needham analyst Mike Matson maintains Artivion (NYSE:AORT) with a Buy and maintains $25 price target.
- Prev
- 1
- Next